Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Revenue

Intellia Therapeutics had revenue of $13.78M in the quarter ending September 30, 2025, with 51.27% growth. This brings the company's revenue in the last twelve months to $57.53M, up 33.52% year-over-year. In the year 2024, Intellia Therapeutics had annual revenue of $57.88M with 59.55% growth.

• Revenue (ttm): $57.53M
• Revenue Growth: +33.52%
• P/S Ratio: 17.51
• Revenue / Employee: $142,749
• Employees: 403
• Market Cap: 1.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.88M	21.60M	59.55%
Dec 31, 2023	36.28M	-15.85M	-30.40%
Dec 31, 2022	52.12M	19.07M	57.69%
Dec 31, 2021	33.05M	-24.94M	-43.01%
Dec 31, 2020	57.99M	14.89M	34.55%
Dec 31, 2019	43.10M	12.67M	41.63%
Dec 31, 2018	30.43M	4.32M	16.53%
Dec 31, 2017	26.12M	9.64M	58.49%
Dec 31, 2016	16.48M	10.44M	172.65%
Dec 31, 2015	6.04M	-	-